[HTML][HTML] Circulating nucleosomes and nucleosome modifications as biomarkers in cancer
Traditionally the stratification of many cancers involves combining tumour and
clinicopathological features (eg, patient age; tumour size, grade, receptor status and …
clinicopathological features (eg, patient age; tumour size, grade, receptor status and …
[HTML][HTML] Cell-free DNA in non-small cell lung cancer
V Gedvilaitė, D Schveigert, S Cicėnas - Acta medica Lituanica, 2017 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer-associated deaths worldwide. Surgery is the
standard treatment for early-stage non-small cell lung cancer (NSCLC). Advances in the …
standard treatment for early-stage non-small cell lung cancer (NSCLC). Advances in the …
[HTML][HTML] Early detection of lung cancer based on DNA methylation analysis in sputum and plasma
E Lianidou, C Alix-Panabières - Translational Cancer Research, 2017 - tcr.amegroups.org
Lung cancer kills millions of people each year in the world and is the main cause of cancer
death in men and the second cause in women (1). Surprisingly, a decade ago, lung cancer …
death in men and the second cause in women (1). Surprisingly, a decade ago, lung cancer …
[PDF][PDF] Exosomes analysis in Non Small Cell Lung Cancer: from in vitro models to preclinical application
M Pucci - 2017 - iris.unipa.it
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths
worldwide. The majority of patients are diagnosed in advanced disease stage. Bone …
worldwide. The majority of patients are diagnosed in advanced disease stage. Bone …